Kalliope
Senior Member (Voting Rights)
Yes it does, so why is it presented by prof. Gundersen as brand new? I think Larun et al are working on a new publication, so am expecting one soon, but this can't be it, can it?It says 2017 at the link.
Yes it does, so why is it presented by prof. Gundersen as brand new? I think Larun et al are working on a new publication, so am expecting one soon, but this can't be it, can it?It says 2017 at the link.
Yes it does, so why is it presented by prof. Gundersen as brand new? I think Larun et al are working on a new publication, so am expecting one soon, but this can't be it, can it?
Prof. Gundersen tweeted about a fresh Cochrane review on CFS and CBT/GET with link to this article, but I can't find the publication date.
Is this brand new?
[...] Due to the nature of the intervention (exercise therapy) and subjectivity of the outcome (self reported fatigue), blinding of therapists, participants, and outcome assessment was structurally scored 0 for all included trials. Hence, this limits the maximal score for methodological quality to 7 out of 10. [...]
[...] The major limitation in the present review is the lack of well reported, sufficiently powered trials that specifically address fatigue. The asymmetrical shape of the funnel plot (Figure 3) is also suggestive of a small-study effect, which may indicate that small negative trials remain unpublished. However, most trials included in the present review were small and underpowered to assess MS-related fatigue (i.e. reflecting the bottom half of the funnel plot). Hence, it is not until larger, sufficiently powered trials are conducted that we can determine the effect of unpublished small trials on the quality of evidence of exercise therapy for fatigue in people with MS. To illustrate, if we consider the SMD of 0.53 for the effect of exercise therapy on fatigue in people with MS, one would need at least 57 participants per trial arm to obtain a statistical power of 80%. From the studies included in the present review, only the study by Carter and colleagues reached such a statistical power (Carter 2014).[...]
The current review shows that exercise therapy can be safely prescribed and is moderately effective in the treatment of fatigue in people with MS without increasing the risk of relapse [...]
Just to broaden the perspective: Not only the Cochrane "Common Mental Disorders Group" but also the Cochrane "Multiple Sclerosis and Rare Diseases of the CNS Group" appears to have questionable standards of assessing research quality:
I think we can close down all labs, medical research and scientific development and just put up posters on every street corner saying, "an apple a day keeps the doctor away".
Do rehabilitationists in general use their imagination much to think of other forms of rehabilitation than exercise?It certainly looks as if the neurorehabilitationists have joined forces with the liaison psychiatrists on this. In the UK pals of Sharpe like Stone and MacLeod appear to take this peculiar approach to evidence quality.
Do rehabilitationists in general use their imagination much to think of other forms of rehabilitation than exercise?
Yet, are the authors of this review actually rehabilitationists?
Clicking on each name reveals that they all work in Rehabilitation units.
Essentially we have the equivalent of psychotherapists: physiotherapists. It looks as if Cochrane is happy for the relevant therapists, and their overlords, to review therapist-delivered treatments. I think this is probably something which should come to a stop. Therapists are different from doctors in that they ARE the treatment. So their ability to be disinterested is much less. Doctors are bad enough. Doctors whose work specifically consists of herding around therapists to do the work are pretty much like the therapists.
Having communicated with Iain Chalmers about the GET review situation I have come to realise that there is a political agenda behind Cochrane that is essentially anti-drug, and as part of this pro-therapy.
Having communicated with Iain Chalmers about the GET review situation I have come to realise that there is a political agenda behind Cochrane that is essentially anti-drug, and as part of this pro-therapy.
What does Cochrane hope to achieve with an anti-drug stance? And does this apply only to ME/CFS or everything?
I don't think it is a matter of hoping to achieve. I just sense that many of these organisations, whether Cochrane, Sense About Science or whatever tend to be set up by people with some sort of political agenda. A very popular political agenda is anti-drug, anti-'biomedical model' etc. Chalmers seems to have left Cochrane per se but I think there may be people still there who have a similar emotional bent under the surface. One may be Paul Glasziou, who was a co-author on the recent Larun, White, Sharpe, Uncle Tom Cobblers and all effort.
There are vultures flying around desperately trying to destroy the NHS and turn everything private.
We keep hearing "we cant afford the NHS anymore"
Thank you, @Jonathan Edwards.
In any case, I think we need strong allies outside Cochrane and outside the ME field.
I started looking for such allies in the MS research field (see https://www.s4me.info/threads/objec...tiguability-lurija-institute.4241/#post-91599 )
But I lack medical expertise to assess the quality of this research.
Perhaps neuropsychiatrists / neuropsychologists might be supportive of criticizing Cochrane? [eta: ] I think there is also a lack of evidence for treatments in this area ("brain jogging" and the like, yet also drugs).
To rich (and maybe mostly "important") people?Where the eff is the money going?
Authors' conclusions (Abstract)
Patients with CFS may generally benefit and feel less fatigued following exercise therapy, and no evidence suggests that exercise therapy may worsen outcomes. A positive effect with respect to sleep, physical function and self-perceived general health has been observed, but no conclusions for the outcomes of pain, quality of life, anxiety, depression, drop-out rate and health service resources were possible. The effectiveness of exercise therapy seems greater than that of pacing but similar to that of CBT. Randomised trials with low risk of bias are needed to investigate the type, duration and intensity of the most beneficial exercise intervention.
(bolding and underlining added)
Implications for practice
Encouraging evidence suggests that exercise therapy can contribute to alleviation of some symptoms of CFS, especially fatigue. Exercise therapy seems to perform better than no intervention or pacing and seems to lead to results similar to those seen with cognitive behavioural therapy. Reported results were obtained from patients who were able to participate (not from those too disabled to attend clinics) [...]
We think the evidence suggests that exercise therapy might be an effective and safe intervention for patients able to attend clinics as outpatients.
(bolding and underlining added)
What questions does this review aim to answer?
• Is exercise therapy more effective than ‘passive’ treatments (e.g. waiting list, treatment as usual, relaxation, flexibility)?
• Is exercise therapy more effective than other ‘active’ therapies (e.g. cognitive-behavioural therapy (CBT), pacing, medication)?
• Is exercise therapy more effective when combined with another treatment than when given alone?
• Is exercise therapy safer than other treatments?
What does evidence from the review tell us?
Moderate-quality evidence showed exercise therapy was more effective at reducing fatigue compared to ‘passive’ treatment or no treatment. Exercise therapy had a positive effect on people’s daily physical functioning, sleep and self-ratings of overall health.
One study suggests that exercise therapy was more effective than pacing strategies for reducing fatigue. However exercise therapy was no more effective than CBT.
Exercise therapy did not worsen symptoms for people with CFS. Serious side effects were rare in all groups, but limited information makes it difficult to draw firm conclusions about the safety of exercise therapy.
Evidence was not sufficient to show effects of exercise therapy on pain, use of other healthcare services, or to allow assessment of rates of drop-out from exercise therapy programmes.
Since when has pacing been a "therapy", let alone an 'active' one?• Is exercise therapy more effective than other ‘active’ therapies (e.g. cognitive-behavioural therapy (CBT), pacing, medication)?